Feasibility of using mr enterography for the assessment of terminal ileitis and inflammatory activity in children with crohn disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 2, 2012, Pages 173-177

  Silverstein, Jared ^a   Grand, David ^a   Kawatu, David ^a   Shah, Samir A ^a   Steinkeler, Jill ^a   Leleiko, Neal ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

crohn disease; MR enterography; radiation

Indexed keywords

GADOLINIUM; WATER;

ADULT; BIOPSY TECHNIQUE; CHILD; CLINICAL ASSESSMENT; COLONOSCOPY; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HUMAN; ILEITIS; INFLAMMATION; INTERMETHOD COMPARISON; MAGNETIC RESONANCE ENTEROGRAPHY; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; BIOPSY; CHILD; COLONOSCOPY; CROHN DISEASE; GADOLINIUM; HUMANS; ILEITIS; ILEUM; INFLAMMATION; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; WATER;

EID: 84863844283     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318249595d     Document Type: Review

References (30)

1. Lin MF, Narra V. Developing role of magnetic resonance imaging in Crohn's disease. Curr Opin Gastroenterol 2008;24:135-40.
2. Toma P, Granata C, Magnano G, et al. CT and MRI of paediatric Crohn disease. Pediatr Radiol 2007;37:1083-92.
3. Darge K, Anupindi SA, Jaramillo D. MR imaging of the bowel: pediatric applications. Magn Reson Imaging Clin N Am 2008;16: 467-78.
4. Committee to Assess Health Risks from Exposure to Low Levels of Radiation, National Research Council. Health Risks from Exposure to Low Levels of Radiation: BEIR VII phase 2. http://dels.nas.edu/dels/ rpt-briefs/beir-vii- final.pdf.
5. Brenner DJ, Elliston CD, Hall EJ, et al. Estimated risks of radiationinduced fatal cancer from pediatric CT. AJR 2001;176:2889-3296.
6. Brenner DJ, Hall EJ. Computed tomography-an increasing source of radiation exposure. N Engl J Med 2007;357:2277-84.
7. Riimola J, Rodriguez S, Garc?́a-Bosch O, et al. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease. Gut 2009;58:1113-20.
8. Koh DM, Miao Y, Chinn RJ, et al. MRimaging evaluation of the activity of Crohn's disease. AJR 2001;177:1325-32.
9. Florie J, Horsthuis K, Hommes DW, et al. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease. Clin Gastroenterol Hepatol 2005;3:1221-8.
10. Girometti R, Zuiani C, Toso F, et al. MRI scoring system including dynamic motility evaluation in assessing the activity of Crohn's disease of the terminal ileum. Acad Radiol 2008;15:153-64.
11. Del Vescovo R, Sansoni I, Caviglia R, et al. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging 2008;33:417-24.
12. Florie J, Wasser MN, Arts-Cieslik K, et al. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease activity in Crohn's disease. AJR 2006;186:1384-92.
13. Bernstein CN, Greenberg H, Boult I, et al. A prospective comparison study of MRI versus small bowel follow-through in recurrent Crohn's disease. Am J Gastroenterol 2005;100:2493-502.
14. Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small-bowel Crohn's disease. AJR 2009;193:113-21.
15. Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology 2009;251:751-61.
16. Punwani S, Rodriguez-Justo M, Bainbridge A, et al. Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features. Radiology 2009;252:712-20.
17. Horsthuis K, Bipat S, Bennink R, et al. Inflammatory bowel disease diagnosed with US, MR, scintigraphy, and CT: meta-analysis of prospective studies. Radiology 2008;247:64-79.
18. Pilleul F, Godefroy C, Yzebe-Beziat D, et al. Magnetic resonance imaging in Crohn's disease. Gastroenterol Clin Biol 2005;29:803-8.
19. Magnano G, Granata C, Barabino A, et al. Polyethylene glycol and contrast-enhanced MRI of Crohn's disease in children: preliminary experience. Pediatr Radiol 2003;33:385-91.
20. Laghi A, Borrelli O, Paolantonio P, et al. Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease. Gut 2003;52:393-7.
21. Laghi A, Paolantonio P, Iafrate F, et al. MR of the small bowel with a biphasic oral contrast agent (polyethylene glycol): technical aspects and findings in patients affected by Crohn's disease. Radiol Med 2003; 106:18-27.
22. Young BM, Fletcher JG, Booya F, et al. Head-to-head comparison of oral contrast agents for cross-sectional enterography: small bowel distension, timing, and side effects. J Comput Assist Tomogr 2008; 32:32-8.
23. Kuehle CA, Ajaj W, Ladd SC, et al. Hydro-MRI of the small bowel: effect of contrast volume, timing of contrast administration, and data acquisition on bowel distension. AJR 2006;187:W375-85.
24. Young BM, Fletcher JG, Booya F, et al. Head-to-head comparison of oral contrast agents for cross-sectional enterography: small bowel distension, timing, and side effects. J Comput Assist Tomogr 2008; 32:32-8.
25. Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
26. Hyams J, Markowitz J, Otley A, et al. Evaluation of the Pediatric Crohn's Disease Activity Index: a prospective multicenter experience. J Pediatr Gastroenterol Nutr 2005;41:416-21.
27. Siddiki H, Fidler J. MR imaging of the small bowel in Crohn's disease. Eur J Radiol 2009;69:409-17.
28. Maccioni F, Bruni A, Viscido A, et al. MR imaging in patients with Crohn's disease: value of T2-versus T1-weighted gadolinium-enhanced mr sequences with use of an oral superparamagnetic contrast agent. Radiology 2006;238:517-30.
29. Inflammatory Bowel Disease Genetics Consortium. Phenotype Operating Manual: Guidelines for Recruiting Individuals to the IBD Genetics Consortium and Detailed Forms for Phenotyping Crohn's Disease, Ulcerative Colitis, Indeterminate Colitis, and Unaffected Controls. http://medicine.yale.edu/intmed/ ibdgc/resources/81330-Phenotyping-Manual-2.9.11.pdf.
30. Baert F, Moortgat L, Van Assche G, et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010;138:463-8.